Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Get more Watchlists, Portfolios, Custom Views and Chart Templates with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Fennec Pharmaceuticals Inc (FENC)

Fennec Pharmaceuticals Inc (FENC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 164,764
  • Shares Outstanding, K 27,324
  • Annual Sales, $ 21,250 K
  • Annual Income, $ -16,050 K
  • 60-Month Beta 0.29
  • Price/Sales 7.75
  • Price/Cash Flow N/A
  • Price/Book 54.94
Trade FENC with:

Options Overview Details

View History
  • Implied Volatility 172.22% ( +47.40%)
  • Historical Volatility 38.50%
  • IV Percentile 97%
  • IV Rank 55.07%
  • IV High 294.16% on 06/21/24
  • IV Low 22.77% on 06/14/24
  • Put/Call Vol Ratio 0.00
  • Today's Volume 1
  • Volume Avg (30-Day) 9
  • Put/Call OI Ratio 0.17
  • Today's Open Interest 308
  • Open Int (30-Day) 291

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 6 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/24
See More
  • Average Estimate 0.07
  • Number of Estimates 3
  • High Estimate 0.42
  • Low Estimate -0.15
  • Prior Year -0.21
  • Growth Rate Est. (year over year) +133.33%

Price Performance

See More
Period Period Low Period High Performance
1-Month
5.97 +1.01%
on 07/03/24
7.31 -17.51%
on 06/12/24
-0.70 (-10.40%)
since 06/03/24
3-Month
5.97 +1.01%
on 07/03/24
11.15 -45.92%
on 04/04/24
-4.74 (-44.01%)
since 04/03/24
52-Week
5.97 +1.01%
on 07/03/24
11.92 -49.41%
on 12/28/23
-2.54 (-29.64%)
since 07/03/23

Most Recent Stories

More News
Fennec Pharmaceuticals Announces Up to $45 Million Investment From Petrichor

~ Under the Terms of the Investment Agreement, $5 Million to be Funded on initial closing and $20 Million to be Funded Upon Potential FDA Approval of...

FRX.TO : 8.16 (-1.21%)
FENC : 6.03 (unch)
Chart of the Day: Fennec Pharmaceuticals --- BioPharma

The Chart of the Day belongs to the healthcare biotech company Fennec Pharmaceuticals (FENC) Barchart's Top Stocks to Own list first by the most frequent number of new highs in the last month, then used...

FENC : 6.03 (unch)
Fennec Announces Results of Annual Meeting

RESEARCH TRIANGLE PARK, N.C., June 14, 2022 (GLOBE NEWSWIRE) -- Fennec Pharmaceuticals Inc. (the “Company”) (NASDAQ:FENC) (TSX:FRX) today announced that...

FENC : 6.03 (unch)
FRX.TO : 8.16 (-1.21%)
Fennec Pharmaceuticals to Participate in Upcoming Investor Conferences

RESEARCH TRIANGLE PARK, N.C., May 23, 2022 (GLOBE NEWSWIRE) -- Fennec Pharmaceuticals Inc. (NASDAQ:FENC; TSX: FRX), a specialty pharmaceutical company...

FRX.TO : 8.16 (-1.21%)
FENC : 6.03 (unch)
Fennec Pharmaceuticals Announces First Quarter 2022 Financial Results and Provides Business Update

~ FDA Prescription Drug User Fee Act (PDUFA) Target Action Date Set for September 23, 2022 ~ ~ If Approved by the FDA, PEDMARKTM Stands to Be the First...

FRX.TO : 8.16 (-1.21%)
FENC : 6.03 (unch)
Fennec Pharmaceuticals Announces FDA Acceptance for Filing of New Drug Application Resubmission for PEDMARK™

~ Prescription Drug User Fee Act (PDUFA) target action date set for September 23, 2022 ~...

FRX.TO : 8.16 (-1.21%)
FENC : 6.03 (unch)
FENC Final Deadline: Bronstein, Gewirtz & Grossman, LLC Reminds Fennec Pharmaceuticals Inc. Investors of Class Action and Last Few Hours to Contact the Firm

Attorney Advertising--Bronstein, Gewirtz & Grossman, LLC notifies investors that a class action lawsuit has been filed against Fennec Pharmaceuticals Inc. ("Fennec" or the "Company") (NASDAQ: FENC) and...

FENC : 6.03 (unch)
The Law Offices of Frank R. Cruz Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Fennec Pharmaceuticals Inc. (FENC)

The Law Offices of Frank R. Cruz reminds investors of the upcoming April 11, 2022 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who acquired Fennec Pharmaceuticals...

FENC : 6.03 (unch)
Fennec Pharmaceuticals to Participate in the 2022 Maxim Virtual Growth Conference

RESEARCH TRIANGLE PARK, N.C., March 25, 2022 (GLOBE NEWSWIRE) -- Fennec Pharmaceuticals Inc. (NASDAQ: FENC; TSX: FRX), a specialty pharmaceutical company...

FRX.TO : 8.16 (-1.21%)
FENC : 6.03 (unch)
Fennec Pharmaceuticals Resubmits New Drug Application to U.S. Food and Drug Administration for Pedmark™

RESEARCH TRIANGLE PARK, N.C., March 24, 2022 (GLOBE NEWSWIRE) -- Fennec Pharmaceuticals Inc. (NASDAQ:FENC; TSX: FRX), a specialty pharmaceutical company,...

FRX.TO : 8.16 (-1.21%)
FENC : 6.03 (unch)

Business Summary

Fennec Pharmaceuticals Inc. is a clinical-stage biotechnology company. It is focused on the development of Sodium Thiosulfate for the prevention of ototoxicity from cisplatin in pediatric patients. The Company's products include Eniluracil and Sodium Thiosulfate (STS). Fennec Pharmaceuticals Inc., formerly...

See More

Key Turning Points

3rd Resistance Point 6.19
2nd Resistance Point 6.14
1st Resistance Point 6.08
Last Price 6.03
1st Support Level 5.97
2nd Support Level 5.92
3rd Support Level 5.86

See More

52-Week High 11.92
Fibonacci 61.8% 9.65
Fibonacci 50% 8.94
Fibonacci 38.2% 8.24
Last Price 6.03
52-Week Low 5.97

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar